作者: Kojiro Michitaka , Norio Horiike , Masao Miyagawa , Morikazu Onji , Yoichi Hiasa
DOI:
关键词:
摘要: BACKGROUND/AIMS Transcatheter arterial chemoembolization (TACE) has been reported as effective therapy for unresectable hepatocellular carcinoma (HCC), however, few have described methods predicting prognosis, especially in patients treated by repeated TACE. To determine risk factors death and try to predict the we evaluated clinical data. METHODOLOGY We retrospectively analyzed parameters of 224 with HCC TACE from January 1997 December 2007. was when recurrence diagnosed tumor marker elevation and/or dynamic computed tomography findings. Factors affecting survival were using multivariate analysis after univariate analysis. Next, combined score each significant factor into a single prognostic added up positive case, then significance which results compared other scoring systems. RESULTS Multivariate revealed that bilobular HCC, alpha-fetoprotein (> or = 400 ng/ml), invasion portal vein, size 10 cm), albumin (< 2.8 g/dl) related poor developed system those. According score, classified 5 groups. CONCLUSION Our easily performed showed should not be administered scores 3 more.